Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
304 USD | +0.99% | -0.33% | +5.83% |
May. 28 | US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment | RE |
May. 28 | Amgen's Rare-Disease Treatment Biosimilar Bkemv Gets FDA Approval | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.83% | 161B | |
+39.36% | 734B | |
+32.83% | 591B | |
-6.11% | 350B | |
+14.94% | 315B | |
+2.20% | 276B | |
+15.00% | 238B | |
+9.78% | 206B | |
-5.52% | 204B | |
-1.25% | 160B |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- Sector Update: Health Care Stocks Steady Late Afternoon